Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$11.06 - $14.01 $115,024 - $145,704
-10,400 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$5.71 - $15.85 $244,959 - $679,965
-42,900 Reduced 80.49%
10,400 $80,000
Q4 2019

Feb 11, 2020

BUY
$9.6 - $17.75 $344,640 - $637,225
35,900 Added 206.32%
53,300 $813,000
Q2 2019

Aug 12, 2019

BUY
$9.44 - $19.8 $164,256 - $344,520
17,400 New
17,400 $344,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.